MP
GRNA

Mangrove Partners’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Mangrove Partners’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200,000
Closed -$1.96M – 400
2021
Q2 		$1.96M Buy
+200,000
New +$1.95M 0.2% 152

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Mangrove Partners's GRNA Position: Q3 2021 in Review

Mangrove Partners sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2021, closing a stake of 200,000 shares — an estimated $1.96M sold.

Mangrove Partners first reported a position in GRNA in Q2 2021 and held it in 1 quarter. The position peaked at $1.96M in Q2 2021. 70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Mangrove Partners reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2021 after selling out during the quarter.
  • Mangrove Partners sold 200,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2021, an estimated $1.96M.
  • Mangrove Partners first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 1 quarter.
  • Mangrove Partners's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.96M in Q2 2021.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.